论文部分内容阅读
目的:观测阿奇霉素联合利巴韦林治疗小儿支原体肺炎的临床疗效。方法:治疗组90例,予以阿奇霉素和利巴韦林治疗;对照组90例,予以阿奇霉素治疗。结果:治疗组和对照组总有效率分别为为97.78%和86.66%,两组总有效率比较差异具有统计学意义(P<0.05)。结论:小儿支原体肺炎多合并病毒双重感染,阿奇霉素联合利巴韦林治疗效果显著,病程短,值得临床推广。
Objective: To observe the clinical efficacy of azithromycin combined with ribavirin in the treatment of children with mycoplasma pneumonia. Methods: The treatment group of 90 patients were treated with azithromycin and ribavirin; control group of 90 patients were treated with azithromycin. Results: The total effective rates of the treatment group and the control group were 97.78% and 86.66%, respectively. There was significant difference between the two groups in the total effective rate (P <0.05). Conclusion: Mycoplasma pneumonia combined with multiple virus infection in children, azithromycin combined with ribavirin significant effect, short course, worthy of clinical promotion.